|
TREX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.158000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.112000E-01 |
| Normal-vs-Stage2 |
1.945910E-02 |
| Normal-vs-Stage3 |
3.167000E-01 |
| Normal-vs-Stage4 |
2.816200E-01 |
| Stage1-vs-Stage2 |
1.230010E-02 |
| Stage1-vs-Stage3 |
4.311600E-01 |
| Stage1-vs-Stage4 |
3.679400E-01 |
| Stage2-vs-Stage3 |
1.402840E-01 |
| Stage2-vs-Stage4 |
3.854800E-01 |
| Stage3-vs-Stage4 |
7.900200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.790400E-01 |
| Normal-vs-AfricanAmerican |
1.736560E-01 |
| Normal-vs-Asian |
6.922000E-01 |
| Caucasian-vs-AfricanAmerican |
4.382600E-01 |
| Caucasian-vs-Asian |
1.914170E-01 |
| AfricanAmerican-vs-Asian |
1.364180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.637200E-01 |
| Normal-vs-Female |
2.182800E-01 |
| Male-vs-Female |
2.095800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.984800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.466420E-01 |
| Normal-vs-Age(61-80Yrs) |
2.263200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.726200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.599630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.923600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.278800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.933000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.288600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.457000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.784900E-03 |
| Classical-VS-Follicular |
6.099200E-01 |
| Classical-VS-Other |
6.692000E-01 |
| Classical-VS-Normal |
2.822800E-01 |
| Tall-VS-Follicular |
1.153880E-02 |
| Tall-VS-Other |
2.998000E-01 |
| Tall-VS-Normal |
5.277200E-03 |
| Follicular-VS-Other |
6.620000E-01 |
| Follicular-VS-Normal |
5.910200E-01 |
| Other-VS-Normal |
8.809800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.100200E-01 |
| Normal-vs-N1 |
5.596000E-01 |
| N0-vs-N1 |
7.167200E-01 |
|
|
